Saint-Gobain Life Sciences launches EUR 70M global expansion of seven manufacturing sites

Saint-Gobain Life Sciences is investing over EUR 70 million over three years to expand or build manufacturing facilities at seven sites in the USA, France, Ireland, India, China and South Korea, all due to be operational by the end of 2020.

“Saint-Gobain is investing over €70M through a 3-year period to increase manufacturing capacity”biospace.com

• 1 source
• biospace.comSaint-Gobain Life Sciences Completes Second of Seven Manufacturing Expansions as Part of Global Facility Expansion Program - BioSpaceGabrielle MassonNov 21, 2019

Summarized from public sources; check the original articles before acting on it.